At close: January 2 at 4:00:01 PM EST
After hours: 7:59:38 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-6,906.53
-7,239.51
-3,875.81
-4,489.44
-3,136.12
Investing Cash Flow
-100.00
--
--
-1,750.00
--
Financing Cash Flow
6,732.47
4,917.35
5,487.56
8,216.03
2,899.00
End Cash Position
1,137.45
1,469.13
3,791.30
2,179.56
202.97
Capital Expenditure
--
--
--
-1,750.00
--
Issuance of Capital Stock
4,969.97
5,292.35
3,271.49
10,136.50
1,067.50
Issuance of Debt
2,000.00
650.00
--
77.60
2,081.50
Repayment of Debt
-937.50
-1,225.00
-2,417.00
-1,700.00
-250.00
Repurchase of Capital Stock
--
--
--
-247.17
--
Free Cash Flow
-6,906.53
-7,239.51
-3,875.81
-6,239.44
-3,136.12
12/31/2020 - 12/17/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SPRC SciSparc Ltd.
0.3926
+9.06%
VINC Vincerx Pharma, Inc.
0.2353
-10.46%
ONCO Onconetix, Inc.
0.6511
+3.35%
NLSP NLS Pharmaceutics AG
2.1800
+3.32%
APM Aptorum Group Limited
2.2000
-21.43%
PLRZ Polyrizon Ltd.
1.8300
-15.67%
EVAX Evaxion Biotech A/S
0.9242
+10.98%
MRNS Marinus Pharmaceuticals, Inc.
0.5340
-0.21%
VRPX Virpax Pharmaceuticals, Inc.
0.3745
+1.38%
CERO CERo Therapeutics Holdings, Inc.
0.0610
+1.67%